| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.
|
Circulation
|
2005
|
18.90
|
|
2
|
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
|
Circulation
|
2009
|
9.26
|
|
3
|
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
|
Circulation
|
2009
|
8.93
|
|
4
|
2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.
|
J Am Coll Cardiol
|
2009
|
7.38
|
|
5
|
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.
|
JAMA
|
2005
|
6.10
|
|
6
|
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.
|
J Am Coll Cardiol
|
2009
|
5.76
|
|
7
|
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
|
N Engl J Med
|
2003
|
4.61
|
|
8
|
Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.
|
Eur Heart J
|
2006
|
4.55
|
|
9
|
Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.
|
Circulation
|
2003
|
4.25
|
|
10
|
Decision making in advanced heart failure: a scientific statement from the American Heart Association.
|
Circulation
|
2012
|
3.61
|
|
11
|
Spironolactone in chronic heart failure:all's well that ends well.
|
J Am Coll Cardiol
|
2003
|
2.47
|
|
12
|
Sodium nitroprusside for advanced low-output heart failure.
|
J Am Coll Cardiol
|
2008
|
2.47
|
|
13
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.
|
J Am Coll Cardiol
|
2012
|
2.44
|
|
14
|
Animal models of heart failure: a scientific statement from the American Heart Association.
|
Circ Res
|
2012
|
2.31
|
|
15
|
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
|
Arch Intern Med
|
2003
|
2.29
|
|
16
|
A new, precise definition of acute myocardial infarction.
|
Cleve Clin J Med
|
2009
|
2.18
|
|
17
|
Practicing 'check the box' medicine.
|
Am J Med
|
2013
|
2.00
|
|
18
|
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
|
Arch Intern Med
|
2007
|
1.98
|
|
19
|
Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system.
|
J Am Coll Cardiol
|
2008
|
1.95
|
|
20
|
Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
|
J Am Coll Cardiol
|
2008
|
1.95
|
|
21
|
Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?
|
J Am Coll Cardiol
|
2008
|
1.87
|
|
22
|
Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.
|
Circulation
|
2010
|
1.84
|
|
23
|
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.
|
J Am Coll Cardiol
|
2003
|
1.70
|
|
24
|
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2006
|
1.69
|
|
25
|
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.
|
Congest Heart Fail
|
2004
|
1.66
|
|
26
|
Cardiac troponins in renal insufficiency: review and clinical implications.
|
J Am Coll Cardiol
|
2002
|
1.63
|
|
27
|
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
|
J Thorac Cardiovasc Surg
|
2004
|
1.63
|
|
28
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
Ann Thorac Surg
|
2012
|
1.59
|
|
29
|
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
|
J Am Coll Cardiol
|
2008
|
1.48
|
|
30
|
Advanced heart failure and transplant cardiology: a subspecialty is born.
|
J Am Coll Cardiol
|
2009
|
1.48
|
|
31
|
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
|
Circulation
|
2007
|
1.39
|
|
32
|
The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure.
|
J Am Coll Cardiol
|
2002
|
1.34
|
|
33
|
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
|
Circulation
|
2004
|
1.33
|
|
34
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
J Thorac Cardiovasc Surg
|
2012
|
1.28
|
|
35
|
Pathophysiologic targets in the early phase of acute heart failure syndromes.
|
Am J Cardiol
|
2005
|
1.27
|
|
36
|
ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction?
|
J Am Coll Cardiol
|
2006
|
1.24
|
|
37
|
Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial.
|
J Am Coll Cardiol
|
2004
|
1.23
|
|
38
|
Impact of myocardial function on cystatin C measurements in chronic systolic heart failure.
|
J Card Fail
|
2008
|
1.18
|
|
39
|
Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.
|
Circulation
|
2004
|
1.17
|
|
40
|
Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association.
|
Circulation
|
2012
|
1.16
|
|
41
|
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.
|
J Heart Lung Transplant
|
2002
|
1.16
|
|
42
|
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
|
Eur Heart J
|
2008
|
1.15
|
|
43
|
Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.
|
J Card Fail
|
2009
|
1.04
|
|
44
|
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
|
Am J Cardiol
|
2009
|
0.99
|
|
45
|
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
|
Eur Heart J
|
2004
|
0.98
|
|
46
|
Statin treatment for patients with heart failure.
|
Nat Rev Cardiol
|
2010
|
0.94
|
|
47
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
|
Clin Biochem
|
2007
|
0.93
|
|
48
|
Prognostic evaluation of ambulatory patients with advanced heart failure.
|
Am J Cardiol
|
2008
|
0.93
|
|
49
|
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training.
|
J Am Coll Cardiol
|
2010
|
0.93
|
|
50
|
Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure.
|
J Card Fail
|
2008
|
0.92
|
|
51
|
Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure.
|
Clin Cornerstone
|
2005
|
0.91
|
|
52
|
Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial.
|
J Card Fail
|
2005
|
0.89
|
|
53
|
Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: what are the nuances?
|
Cleve Clin J Med
|
2004
|
0.89
|
|
54
|
Heart failure therapy at a crossroad: are there limits to the neurohormonal model?
|
J Am Coll Cardiol
|
2003
|
0.89
|
|
55
|
Outcomes of patients with stable heart failure undergoing elective noncardiac surgery.
|
Mayo Clin Proc
|
2008
|
0.87
|
|
56
|
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training.
|
Circulation
|
2010
|
0.86
|
|
57
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
Catheter Cardiovasc Interv
|
2012
|
0.85
|
|
58
|
Autologous cell transplantation for the treatment of damaged myocardium.
|
Prog Cardiovasc Dis
|
2002
|
0.85
|
|
59
|
Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure.
|
Am Heart J
|
2005
|
0.84
|
|
60
|
Adverse drug reactions in patients with cardiovascular disease.
|
Curr Probl Cardiol
|
2008
|
0.84
|
|
61
|
Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial.
|
Congest Heart Fail
|
2006
|
0.83
|
|
62
|
The year in heart failure.
|
J Am Coll Cardiol
|
2008
|
0.83
|
|
63
|
Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support.
|
Int J Cardiol
|
2013
|
0.82
|
|
64
|
Beta-blockers and reverse remodeling: what are the implications?
|
Am Heart J
|
2003
|
0.82
|
|
65
|
Aldosterone receptor antagonists in the medical management of chronic heart failure.
|
Mayo Clin Proc
|
2005
|
0.81
|
|
66
|
Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications.
|
Nat Rev Cardiol
|
2009
|
0.81
|
|
67
|
Gender differences in patients admitted with advanced decompensated heart failure.
|
Am J Cardiol
|
2008
|
0.81
|
|
68
|
Anemia and heart failure a new pathway?
|
J Am Coll Cardiol
|
2007
|
0.80
|
|
69
|
Neurohormonal upregulation in heart failure.
|
Heart Fail Clin
|
2005
|
0.80
|
|
70
|
Contractile reserve: are we beginning to understand it?
|
JACC Cardiovasc Imaging
|
2008
|
0.80
|
|
71
|
Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
|
Am J Med
|
2007
|
0.80
|
|
72
|
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.80
|
|
73
|
Contemporary management and research directions in advanced heart failure: where are we going?
|
Congest Heart Fail
|
2011
|
0.79
|
|
74
|
Histamine, mast cells, and heart failure: is there a connection?
|
J Am Coll Cardiol
|
2006
|
0.79
|
|
75
|
Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms.
|
Am J Cardiol
|
2005
|
0.79
|
|
76
|
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.78
|
|
77
|
Highlights of the 2006 scientific sessions of the Heart Failure Society of America: Seattle, Washington, September 10-13, 2006.
|
J Am Coll Cardiol
|
2007
|
0.78
|
|
78
|
Early cardiac resynchronization therapy and reverse remodeling in patients with mild heart failure: is it time?
|
Circulation
|
2009
|
0.78
|
|
79
|
Notice of concern.
|
J Card Fail
|
2013
|
0.78
|
|
80
|
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
|
Cell Transplant
|
2016
|
0.77
|
|
81
|
From B-type natriuretic peptide to green mambas: the process of discovery.
|
J Am Coll Cardiol
|
2008
|
0.77
|
|
82
|
Should we consider aldosterone as the primary screening target for preventing cardiovascular events?
|
J Am Coll Cardiol
|
2005
|
0.77
|
|
83
|
Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection.
|
Circulation
|
2007
|
0.77
|
|
84
|
Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing.
|
J Thorac Cardiovasc Surg
|
2002
|
0.77
|
|
85
|
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
|
Am Heart J
|
2007
|
0.77
|
|
86
|
A hard look at angiotensin receptor blockers in heart failure.
|
J Am Coll Cardiol
|
2004
|
0.77
|
|
87
|
Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.
|
Nat Clin Pract Cardiovasc Med
|
2007
|
0.76
|
|
88
|
Management of heart failure: a brief review and selected update.
|
Cardiol Clin
|
2008
|
0.76
|
|
89
|
Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.
|
Curr Cardiol Rep
|
2012
|
0.76
|
|
90
|
Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality.
|
Heart Fail Rev
|
2014
|
0.76
|
|
91
|
Advanced heart failure and transplant cardiology: a subspecialty is born.
|
J Card Fail
|
2009
|
0.76
|
|
92
|
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.
|
Ann Intern Med
|
2005
|
0.75
|
|
93
|
Reply: applying cluster analysis to data of previously published chronic heart failure trials.
|
J Am Coll Cardiol
|
2015
|
0.75
|
|
94
|
Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model.
|
Am J Physiol Heart Circ Physiol
|
2004
|
0.75
|
|
95
|
The difficult task of evaluating how to monitor patients with heart failure.
|
J Card Fail
|
2005
|
0.75
|
|
96
|
It is all about heart rate. Or is it?
|
J Am Coll Cardiol
|
2012
|
0.75
|
|
97
|
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment.
|
Congest Heart Fail
|
2002
|
0.75
|
|
98
|
Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
|
Circulation
|
2011
|
0.75
|
|
99
|
Exploring new drugs for heart failure: the case of urocortin.
|
Eur Heart J
|
2007
|
0.75
|
|
100
|
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?
|
JAMA
|
2004
|
0.75
|
|
101
|
Ask the doctors. I have prominent varicose veins on both legs. They hurt, and I don't like how they look. How can I get rid of them?
|
Heart Advis
|
2003
|
0.75
|
|
102
|
Ask Dr. Francis. I am taking a medication called rofecoxib for knee arthritis, and it works well. But I've heard reports that this type of medication may be dangerous for people with heart disease. Should I be worried?
|
Heart Advis
|
2002
|
0.75
|
|
103
|
On being smart. The value of creativity in research.
|
J Card Fail
|
2011
|
0.75
|
|
104
|
I recently received a letter from my cardiologist, and among other diagnoses listed was "sick sinus syndrome." What does this mean?
|
Heart Advis
|
2002
|
0.75
|
|
105
|
Ask the doctors. My doctor said recently that I have pre-diabetes. What does that mean?
|
Heart Advis
|
2003
|
0.75
|
|
106
|
Where have all the clinical trials gone?
|
J Card Fail
|
2011
|
0.75
|
|
107
|
How important is it to drink eight glasses of water every day? I try to do that, but often am able to get only about six glasses in.
|
Heart Advis
|
2002
|
0.75
|
|
108
|
I had bypass surgery performed nine years ago. Three grafts were placed from my leg veins. About two months ago, I developed the same pain that I had before my bypass surgery. Is this just in my head, or should I be worried?
|
Heart Advis
|
2002
|
0.75
|
|
109
|
The Heart Failure Society of America in 2020: a vision for the future.
|
J Card Fail
|
2012
|
0.75
|
|
110
|
Stage B, a pre-cursor of heart failure.
|
Heart Fail Clin
|
2011
|
0.75
|
|
111
|
Ask Dr. Francis. I just had a cardiac catheterization for chest pain. My cardiologist said he saw a 50 percent narrowing in one of the arteries. I was surprised when he didn't perform an angioplasty but instead just recommended some medications. Why not stent the 50 percent blockage?
|
Heart Advis
|
2002
|
0.75
|
|
112
|
In heart failure, all beta-blockers are not necessarily equal.
|
Cleve Clin J Med
|
2003
|
0.75
|
|
113
|
Stage B, a precursor of heart failure, part II.
|
Heart Fail Clin
|
2012
|
0.75
|
|
114
|
Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association.
|
Circulation
|
2017
|
0.75
|
|
115
|
Almost daily I have read about advances in genetics. Will this translate into better treatments for heart disease?
|
Heart Advis
|
2002
|
0.75
|
|
116
|
The year in heart failure.
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
117
|
Vasopressin receptor antagonists in the management of acute heart failure.
|
Expert Opin Investig Drugs
|
2005
|
0.75
|
|
118
|
I have severe coronary artery disease and have been receiving chelation therapy. When I mentioned this to my doctor, he said I was wasting my money, and that I ought to stop. What do you think?
|
Heart Advis
|
2002
|
0.75
|
|
119
|
I have tried everything I can think of to lose weight on my own and am now thinking of using weight-loss medications. Are they safe?
|
Heart Advis
|
2002
|
0.75
|
|
120
|
The year in heart failure.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
121
|
The year in heart failure.
|
J Am Coll Cardiol
|
2006
|
0.75
|
|
122
|
I have arthritis and take ibuprofen. Can ibuprofen cause heart failure?
|
Heart Advis
|
2002
|
0.75
|
|
123
|
β-blockers in stage B: a precursor of heart failure.
|
Heart Fail Clin
|
2012
|
0.75
|
|
124
|
Novel pharmacological treatments for heart failure.
|
Expert Opin Investig Drugs
|
2003
|
0.75
|
|
125
|
I have just been diagnosed with an overactive thyroid. What are the risks to my heart?
|
Heart Advis
|
2002
|
0.75
|
|
126
|
Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy.
|
Curr Cardiol Rep
|
2004
|
0.75
|
|
127
|
Natriuretic peptides and renal insufficiency: clinical significance and role of renal clearance.
|
Heart Fail Clin
|
2006
|
0.75
|
|
128
|
I have been told that I have very weak heart muscle that is causing heart failure. I saw a special on television about implantable pumps. Could one of these help me?
|
Heart Advis
|
2002
|
0.75
|
|
129
|
In praise of idleness.
|
J Card Fail
|
2011
|
0.75
|
|
130
|
I was experiencing shortness of breath and my doctor sent me to a cardiologist. He performed an echocardiogram. The diagnosis was "diastolic dysfunction." What's the significance.
|
Heart Advis
|
2002
|
0.75
|
|
131
|
A 34-year-old man with facial droop and dysarthria.
|
Cleve Clin J Med
|
2003
|
0.75
|
|
132
|
Ask Dr. Francis. I recently had a stroke and was told that the only possible cause the doctors could find was plaque protruding into my aorta. What can be done about this?
|
Heart Advis
|
2002
|
0.75
|
|
133
|
On writing with young people.
|
J Card Fail
|
2013
|
0.75
|
|
134
|
Ask the doctors. I live in a city with high air pollution. Is this a risk factor for heart disease?
|
Heart Advis
|
2003
|
0.75
|
|
135
|
I have congested heart failure and I was recently diagnosed with sleep apnea. Are the two connected?
|
Heart Advis
|
2002
|
0.75
|
|
136
|
Trends and treatment of heart failure developing after acute myocardial infarction.
|
Am Heart Hosp J
|
2003
|
0.75
|
|
137
|
Ask Dr. Francis. I read recently that people with diabetes are at high risk for cardiovascular disease. I have diabetes, but am not aware of any other health problems. What can I do to reduce my risk?
|
Heart Advis
|
2002
|
0.75
|
|
138
|
Ask Dr. Francis. My doctor informed me that my kidneys have started to fail. How does this affect my risk for heart disease?
|
Heart Advis
|
2002
|
0.75
|
|
139
|
During a routine physical, my doctor performed a chest x-ray. He said it showed I have an enlarged heart. What made him say this and should I be worried?
|
Heart Advis
|
2002
|
0.75
|
|
140
|
Ask Dr. Francis. A catheterization revealed a severe narrowing in one of my coronary arteries. My cardiologist recommended that I return for an angioplasty and stent procedure. Should I wait until coated stents are available?
|
Heart Advis
|
2002
|
0.75
|
|
141
|
The year in heart failure.
|
J Am Coll Cardiol
|
2005
|
0.75
|